Home › Funds › MACKAY SHIELDS LLC › DXCM

MACKAY SHIELDS LLC position in DXCM

DEXCOM INC · Health Care

MACKAY SHIELDS LLC reported holding 22,472,000 shares of DXCM (DEXCOM INC) in its Q3 2026 13F filing — a position valued at US$21.3M, representing 0.88% of its reported portfolio and ranking #49 among its reported holdings. MACKAY SHIELDS LLC has disclosed DXCM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)22.47M sh
Reported value held$21.27M
Portfolio Weight0.88%
First reportedQ3 2023
Last changeHold
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How MACKAY SHIELDS LLC's DXCM position evolved

MACKAY SHIELDS LLC first disclosed a stake in DXCM in Q3 2023 at 40,394,000 shares (US$38.2M). The position peaked in Q1 2024 at 41,732,000 shares, worth US$45.9M. Across 13 filings, MACKAY SHIELDS LLC increased the stake 2 time(s), trimmed it 7 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 22,472,000 shares valued at US$21.3M. Notable position changes include a 41% trim in Q1 2025 (shares rose 23% over the following quarter), a 58% increase in Q2 2025 (shares fell 20% over the following quarter), a 25% trim in Q2 2026 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 40.39M $38.24M New
Q4 2023 41.96M $43.98M Add
Q1 2024 41.73M $45.94M Reduce
Q2 2024 41.46M $41.60M Reduce
Q3 2024 41.29M $39.38M Hold
Q4 2024 40.40M $39.02M Reduce
Q1 2025 23.72M $23.11M Reduce
Q2 2025 37.47M $35.30M Add
Q3 2025 37.29M $34.03M Hold
Q4 2025 36.91M $33.98M Reduce
Q1 2026 29.97M $27.63M Reduce
Q2 2026 22.41M $20.92M Reduce
Q3 2026 22.47M $21.27M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DXCM and 13F data

DXCM (DEXCOM INC) is a Health Care company. 27 other funds we track also report a position in DXCM — the largest reported positions include Baillie Gifford & Co (US$996.9M), Castle Hook Partners LP (US$260.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DXCM

All DXCM fund holders →

FAQ

How long has MACKAY SHIELDS LLC held DXCM?

MACKAY SHIELDS LLC has disclosed DXCM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is MACKAY SHIELDS LLC's current position in DXCM?

As of Q3 2026, MACKAY SHIELDS LLC holds 22.47M shares of DXCM (DEXCOM INC), valued at $21.27M, representing 0.88% of its reported portfolio and ranking #49.

Has MACKAY SHIELDS LLC been buying or selling DXCM?

In the latest 13F filing (Q3 2026), MACKAY SHIELDS LLC held unchanged its position in DXCM. The position peaked in Q1 2024 at 41.73M shares.

Which other funds hold DXCM?

Other major institutional holders of DXCM include Baillie Gifford & Co, Castle Hook Partners LP, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.